Assessment of Efficacy and Safety of Tislelizumab for Esophageal Squamous Cell Carcinoma. (2025). Journal of Medical Health Research and Psychiatry, 2(2), 1-9. https://doi.org/10.70844/jmhrp.2025.2.2.43